Literature DB >> 6417337

Spontaneous and mutagen induced sister chromatid exchange in multiple sclerosis.

M S Newton, C M Steel, H J Evans, B Pentland.   

Abstract

Spontaneous and mutagen induced sister chromatid exchange (SCE) frequencies have been studied in nine patients with multiple sclerosis and in nine age and sex matched healthy controls. The incidence of spontaneous SCE in lymphocytes of the MS patients was significantly greater, by about 50%, than in those of the control subjects. When exposed to mitomycin C (MMC) or ethyl methane sulfonate (EMS) in vitro, cells from both groups showed typical dose dependent increases in SCE frequency, with yields from MS patients slightly higher than from controls. The higher SCE yields in mutagen treated MS cells relative to controls is considered to reflect initial basal differences between the cell types, so that MS cells are not intrinsically hypersensitive to mutagen treatment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6417337      PMCID: PMC1049153          DOI: 10.1136/jmg.20.5.372

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  39 in total

1.  An improved rosetting assay for detection of human T lymphocytes.

Authors:  M E Kaplan; C Clark
Journal:  J Immunol Methods       Date:  1974-07       Impact factor: 2.303

2.  New Giemsa method for the differential staining of sister chromatids.

Authors:  P Perry; S Wolff
Journal:  Nature       Date:  1974-09-13       Impact factor: 49.962

3.  Fusion of cultured multiple-sclerosis brain cells with indicator cells: presence of nucleocapsids and virions and isolation of parainfluenza-type virus.

Authors:  V ter Meulen; H Koprowski; Y Iwasaki; Y M Käckell; D Müller
Journal:  Lancet       Date:  1972-07-01       Impact factor: 79.321

4.  HL-A antigens and diseases. I. Multiple sclerosis.

Authors:  C Jersild; A Svejgaard; T Fog; T Ammitzboll
Journal:  Tissue Antigens       Date:  1973

5.  Lymphotoxic activity in multiple sclerosis serum.

Authors:  S Van den Noort; R L Stjernholm
Journal:  Neurology       Date:  1971-08       Impact factor: 9.910

6.  Lymphocyte transformation in multiple sclerosis.

Authors:  M K Jensen
Journal:  Acta Neurol Scand       Date:  1968       Impact factor: 3.209

7.  Herpes simplex virus types 1 and 2 and multiple sclerosis.

Authors:  J R Martin
Journal:  Lancet       Date:  1981-10-10       Impact factor: 79.321

8.  Transformation of lymphocytes from patients with multiple sclerosis. Use of encephalitogen of human origin, with a report of a trial of immunosuppressive therapy in multiple sclerosis.

Authors:  P C Dau; R D Peterson
Journal:  Arch Neurol       Date:  1970-07

9.  Measles and other virus-specific immunoglobulins in multiple sclerosis.

Authors:  M Haire; K B Fraser; J H Millar
Journal:  Br Med J       Date:  1973-09-22

10.  Cell number requirements for lymphocyte stimulation in vitro: changes during the course of multiple sclerosis and the effects of immunosuppression.

Authors:  S C Knight; B Harding; S Burman; J Mertin
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.